ClinicalTrials.gg
CompletedNCT07944898Updated Nov 18, 2026

The Effects of Rigid and Kinesiological Taping, Applied as an Adjunct to Conventional Physical Therapy, on Muscle Strength, Pain, Function, and Joint Position Sense in Individuals With Shoulder Impingement Syndrome

An interventional study of Traditional treatment and rigid taping in Shoulder Impingement Syndrome, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 10 months after the study started (first participant enrolled Dec 2023, registered Nov 2026).
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 70 studies in Shoulder Impingement Syndrome with a site in Turkey — 12 open to participants now, 14 under way, none of them phase 3. Shoulder Impingement Syndrome · Turkey.

Enrollment
27th of 56
48 · median 48
Started
2023
with 8 others
No phase
55 of 70
8 open now
Registered
70th of 70
by date
Lead sponsor
3 of 70
Ankara Yildirim Beyazıt University

Among the 70 studies in Shoulder Impingement Syndrome with a site in Turkey, this one is the 27th largest by enrollment of the 56 interventional ones that give a count, is one of 9 that started in 2023, is one of 55 with no phase, and was the 70th registered.

Shoulder Impingement Syndrome

321 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

12 of the 70 studies in Shoulder Impingement Syndrome with a site in Turkey are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Shoulder Impingement Syndrome with a site in Turkey, or all of them as a file.
02

Study summary

In this study, 48 individuals with shoulder impingement syndrome were divided into three groups to compare the effects of traditional physical therapy, traditional physical therapy combined with rigid taping, and kinesiology taping. After three weeks of treatment, significant improvements in muscle strength, pain, functionality, and joint position sense were observed in all groups. In a comparison between the groups, it was determined that rigid taping was more effective than traditional physical therapy in reducing pain, while both taping methods were more effective than traditional physical therapy in improving functionality and joint position sense. No significant difference was found between the groups in terms of muscle strength.

Read the detailed description

Shoulder impingement syndrome is a common musculoskeletal condition characterized by shoulder pain and functional limitations. Weakness of the rotator cuff muscles, tightness of the posterior capsule, scapular and postural changes, and irritation of the subacromial structures are the primary factors contributing to the development of the syndrome.It has been reported that insufficient muscle strength is a significant risk factor for shoulder injuries, while abnormalities in scapular alignment and movement can negatively affect shoulder mechanics.Proprioception, one of the key components of shoulder function, contributes to neuromuscular control and joint stability by enabling the perception of joint position and movement. It has been shown that a decrease in proprioceptive sensation is associated with various shoulder problems and that joint position sense may be impaired in individuals with shoulder impingement syndrome. Therefore, it is important to assess muscle strength and proprioceptive control in addition to pain and function during treatment.In the conservative treatment of shoulder impingement syndrome, in addition to exercise, manual therapy, and physical agents, rigid and kinesiology taping methods are also used. It has been reported that taping may have an effect on pain, muscle activity, scapular kinematics, and proprioceptive control. However, there are conflicting findings regarding the effects of kinesiology taping, in particular, on proprioception. However, there is insufficient evidence regarding the potential sensorimotor effects of rigid taping in individuals with shoulder impingement syndrome.

In the current literature, there are few studies that compare, within the same study, the effects of rigid and kinesiological taping-when added to traditional physical therapy-on muscle strength, pain, function, and joint position sense. Therefore, a direct comparison of these two taping methods is clinically important.The purpose of this study is to contribute to the development of more comprehensive and effective treatment approaches by comparing the effects of rigid and kinesiological taping-applied in addition to traditional physical therapy-on muscle strength, pain, function, and joint position sense in individuals with shoulder impingement syndrome. This study was conducted as a single-center, three-group, controlled, pre-test-post-test quasi-experimental study. Written informed consent was obtained from all participants.The sample size was calculated using the G*Power 3.1.9.4 software, based on 80% power, a 5% margin of error, three groups, and two measurement time points. The minimum sample size was determined to be 42 based on a moderate effect size (0.25), and 48 participants were included in the study to account for potential dropouts.

The study was conducted with 48 volunteers aged 18-60 who presented to the Physical Therapy and Rehabilitation Clinic at Erzurum City Hospital and were diagnosed with shoulder impingement syndrome by a physician based on MRI findings and a physical examination.The participants' sociodemographic and clinical characteristics were recorded. Muscle strength was assessed using the K-Force hand dynamometer; pain and function were assessed using the SPADI; and joint position sense was assessed using the Goniometer Pro app, both before and after treatment. To prevent any potential effects arising from the order of measurements, the proprioception assessment was performed before the muscle strength measurement.All treatments were administered by a physical therapist. The data were analyzed using SPSS 23. Descriptive statistics were presented as mean, standard deviation, median, minimum and maximum values, and frequency (%). Normal distribution was assessed using the Shapiro-Wilk test, and homogeneity of variances was assessed using the Levene test. For comparisons between groups, ANOVA, Welch's, or Kruskal-Wallis tests were used; for pairwise comparisons, Tukey's, Games-Howell, or Dunn's tests were used. Changes within the group before and after treatment were analyzed using the t-test for paired samples or the Wilcoxon signed-rank test. Categorical variables were compared using the chi-square test or Fisher's exact test. Statistical significance was assessed at the 0.05 level.

03

Conditions studied

  • Shoulder Impingement Syndrome

Keywords

  • shoulder impingement syndrome
  • muscle strength
  • proprioception
  • rehabilitation
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being aged between 18 and 65 years.
  • Having been diagnosed with shoulder impingement syndrome.
  • Voluntarily agreeing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Receiving any other treatment for shoulder impingement syndrome during the study period.
  • Having previously undergone invasive -containing treatment for shoulder impingement syndrome.
  • Having received any treatment for shoulder impingement syndrome within the previous 6 months.
  • Having a history of surgery in the shoulder region.
  • Having a history of shoulder injury.
  • Having any comorbid medical condition.
  • Having a skin allergy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Active comparator
    traditional treatment

    Other: Traditional treatment

  • Experimental
    rigid taping

    Procedure: rigid taping

  • Experimental
    Kinesiology Taping

    Procedure: kinesiology taping

Interventions

  • OtherTraditional treatment

    TENS was applied using two channels and four electrodes, ensuring that the painful area remained within the treatment zone created by the electrodes. The treatment was administered at a frequency of 100 Hz, at an intensity tolerable to the participant, and lasted 20 minutes. The hot pack was applied through 4-6 layers of towel for 20 minutes at a temperature tolerable to the participant. Ultrasound therapy was administered using the full-contact technique via gel at a frequency of 1 MHz, an intensity of 1.5 W/cm², and for a duration of 5 minutes.The therapeutic exercise program consisted of wand exercises targeting shoulder flexion, abduction, and hyperextension; Codman exercises; and isometric exercises targeting flexion, abduction, hyperextension, internal rotation, and external rotation of the shoulder girdle. All exercises were performed under the supervision of a physical therapist, with 10 repetitions of each exercise.

  • Procedurerigid taping

    Rigid taping was applied 3 days a week for 3 weeks-a total of 9 sessions-in addition to the traditional physical therapy program. The tape was left on the skin for 48 hours.

  • Procedurekinesiology taping

    Kinesiology taping was administered 3 days a week for 3 weeks-a total of 9 sessions-in addition to the traditional physical therapy program. The tape was left on the skin for 48 hours. Standard 5-cm-wide Vzn Kinesio Tape (Wuxi, China) was used in the treatment.

06

What researchers measure

Primary outcomes

  1. SPADI (Shoulder Pain and Disability İndex)

    The scale assesses pain and functional status, with higher scores indicating greater pain and lower functionality.

    Time frame: From the registration phase through the end of the 3-week treatment

07

Study locations

1 site
  • Ankara Yıldırım Beyazıt University
    Ankara, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2023 to primary completion in Dec 2024, 12 months.

Of 171 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's 12 months is close to that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 18, 2026
StartActual
Dec 14, 2023
Primary completionActual
Dec 14, 2024
CompletionActual
Dec 14, 2024
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944898
Collaborators
Erzurum City Hospital
Responsible party
Bihter Aslanyurek (professor, Ankara Yildirim Beyazıt University) — Principal investigator
First posted
Nov 18, 2026
Start date
Dec 14, 2023
Primary completion
Dec 14, 2024
Completion
Dec 14, 2024
Last update
Nov 18, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion